From: Becker's Supply Chain Report <editorial@beckershealthcare.com>
Subject: FDA approves 1st biosimilar to treat cancer | 100+ cities compete for Amazon's HQ2 | Tenet explores strategic options, including sale | Physicians rarely disclose pharma payments when promoting drugs on Twitter
Preheader:
Reply: editorial@beckershealthcare.com
View our profile on LinkedIn Follow us on Twitter Like us on Facebook Find us on Google+ View our videos on YouTube

September 15, 2017
TODAY'S TOP STORIES
1. 100+ cities compete for Amazon's HQ2 

2. Tenet explores strategic options, including sale Full story
  
3. Supply chain inefficiencies leave $23B in potential savings on the table for hospitals Full story

4. Straight from the source: Incorporating Patient-Generated Health Data into clinical workflows Learn more
  

5. 4 things Hurricane Harvey taught providers about disaster preparedness Full story 

6. Physicians rarely disclose payments from pharma when promoting drugs on Twitter Full story
 
7. Best Practices for an EHR Go-Live      
  
8. FDA approves 1st biosimilar to treat cancer Full story
 
9. Former Cleveland Clinic executive charged in $2.7M fraud scheme Full story
 
10. Missouri hospital to close next week Full story
  
11. How a robust pack program can help drive product standardization and cost savings. Register here for this upcoming webinar.

12. 5 latest FDA approvals

Call for submissions - "Supply chain tip of the week": If you would like to contribute a tip, insight or best practice related to improving the hospital supply chain, please email Mackenzie Bean at mbean@beckershealthcare.com.  
 


Channels
Contact Us

Editorial Contact: 
Molly Gamble 
Editor-in-Chief
(800) 417-2035
Sales, Marketing & Events:
Jessica Cole
President and CEO
 
Becker's Hospital Review
A Becker's Healthcare Publication
  www.BeckersHospitalReview.com
editorial@beckershealthcare.com
35 E. Wacker Drive, Suite 1782 | Chicago, IL 60601
Becker's Healthcare, 35 E. Wacker, Suite 1782, Chicago, IL 60601
Sent by editorial@beckershealthcare.com in collaboration with
Constant Contact